BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18579756)

  • 1. Matrix metalloproteinase-2 is expressed in melanoma-associated spongiform scleropathy.
    Alyahya GA; Kolko M; Prause JU; Nielsen BS; Wang J; Heegaard S
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2806-11. PubMed ID: 18579756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma associated spongiform scleropathy: characterization, biochemical and immunohistochemical studies.
    Alyahya GA
    Acta Ophthalmol; 2008 Oct; 86 Thesis 3():1-21. PubMed ID: 18826517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.
    Nielsen BS; Sehested M; Kjeldsen L; Borregaard N; Rygaard J; Danø K
    Lab Invest; 1997 Oct; 77(4):345-55. PubMed ID: 9354769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells.
    Ohnishi Y; Tajima S; Ishibashi A
    Eur J Dermatol; 2001; 11(5):420-3. PubMed ID: 11525948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cultured dermal fibroblasts on human melanoma cell proliferation, matrix metalloproteinase-2 (MMP-2) expression and invasion in vitro.
    Ntayi C; Hornebeck W; Bernard P
    Arch Dermatol Res; 2003 Nov; 295(6):236-41. PubMed ID: 14530987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of melanoma associated spongiform scleropathy.
    Alyahya GA; Heegaard S; Prause JU
    Acta Ophthalmol Scand; 2002 Jun; 80(3):322-6. PubMed ID: 12059874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2001; 15(1):57-64. PubMed ID: 11286131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases in wound healing after glaucoma filtration surgery in rabbits.
    Shima I; Katsuda S; Ueda Y; Takahashi N; Sasaki H
    Ophthalmic Res; 2007; 39(6):315-24. PubMed ID: 17957131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
    Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
    Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas.
    Liu W; Kunishio K; Matsumoto Y; Okada M; Nagao S
    J Clin Neurosci; 2005 Sep; 12(7):791-4. PubMed ID: 16198918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
    Hata H; Kitamura T; Higashino F; Hida K; Yoshida K; Ohiro Y; Totsuka Y; Kitagawa Y; Shindoh M
    Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
    Illemann M; Bird N; Majeed A; Sehested M; Laerum OD; Lund LR; Danø K; Nielsen BS
    Mol Cancer Res; 2006 May; 4(5):293-302. PubMed ID: 16687484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase induction in post-transplant obliterative bronchiolitis.
    Eerola LM; Alho HS; Maasilta PK; Inkinen KA; Harjula AL; Litmanen SH; Salminen US
    J Heart Lung Transplant; 2005 Apr; 24(4):426-32. PubMed ID: 15797744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
    Väisänen AH; Kallioinen M; Turpeenniemi-Hujanen T
    Hum Pathol; 2008 Mar; 39(3):377-85. PubMed ID: 18187184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of gelatinase (MMP-2 and MMP-9) in pterygia and pterygium fibroblasts with disease progression and activation of protein kinase C.
    Yang SF; Lin CY; Yang PY; Chao SC; Ye YZ; Hu DN
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4588-96. PubMed ID: 19420332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblasts enhance the invasive capacity of melanoma cells in vitro.
    Wandel E; Raschke A; Hildebrandt G; Eberle J; Dummer R; Anderegg U; Saalbach A
    Arch Dermatol Res; 2002 Feb; 293(12):601-8. PubMed ID: 11875642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma-associated spongiform scleropathy: biochemical changes and possible relation to tumour extension.
    Alyahya GA; Ribel-Madsen SM; Heegaard S; Prause JU; Trier K
    Acta Ophthalmol Scand; 2003 Dec; 81(6):625-9. PubMed ID: 14641266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.